---
title: "23 Biotech Investors in Texas (Nov 2026)"
last_updated: "2026-11-06"
rows: "23"
free_rows: "11"
source: "SEC filings"
canonical: "https://theinvestordatabase.com/lists/biotech-investors-in-texas/"
---

# 23 biotech investors in Texas

We list 23 biotech investors in Texas as of November 2026: each has an SEC filing on file, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are Austin (14), Houston (5) and Dallas (2).

- 23 investors
- 17 with a fund filing or dated deal in the last 12 months
- $50M median fund size on file (SEC Form D, 19 firms)
- 123 named decision-makers on file

## First 11 of 23 biotech investors in Texas

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Gore Range Capital | VC firm | Southlake, TX | Seed | Biotech, Healthtech, Medtech | New deal, Aug 2026 | $250M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/gore-range-capital/ |
| 8VC | VC firm | Austin, TX |  | Biotech, Data, AI, Healthtech | New deal, Oct 2026 | $400M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/8vc-austin-2/ |
| Transpose Platform | VC firm | Houston, TX | Pre-seed | Biotech, AI, Generalist | New fund, Sep 2026 | $500M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/transpose-platform/ |
| JSTAR Capital | VC firm | Austin, TX | Growth | Biotech, Healthtech, AI, Fintech | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/jstar-capital/ |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/shd-partners/ |
| Audere | VC firm | Austin, TX | Growth | Biotech, Cybersecurity, AI, Robotics | New fund, Oct 2026 | $100M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/audere/ |
| Hyve Ventures | VC firm | Austin, TX | Pre-seed | Biotech, Consumer, Healthtech, Logistics | New fund, Nov 2026 | $6M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/hyve-ventures/ |
| Monograph Capital | VC firm | Fort Worth, TX | Pre-seed | Biotech, Healthtech | New deal, Jun 2026 | $326M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/monograph-capital/ |
| First Bight Ventures | VC firm | Houston, TX | Seed, Series A | Biotech, Climate Tech, Healthtech, Industrial Tech | New fund, Mar 2026 | $80M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/first-bight-ventures/ |
| Humain Ventures | VC firm | Austin, TX | Pre-seed, Seed | Biotech, Healthtech, AI, Edtech | New fund, May 2026 | $10M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/humain-ventures/ |
| Next Ventures | VC firm | Austin, TX | Seed | Biotech, Healthtech, AI, Medtech | New fund, Dec 2024 | $100M (SEC Form D, 2024) | 2026-11-05 | https://theinvestordatabase.com/investors/next-ventures/ |

You are seeing 11 of 23. The full list adds 12 more investors and 123 named decision-makers.

Get all 23 investors and 123 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/biotech-investors-in-texas
This page: https://theinvestordatabase.com/lists/biotech-investors-in-texas/

## Method and limits
- Source: All 23 rows carry an SEC filing (Form D or Form ADV). All 23 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Place: head office in Texas.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 23 rows: stage 19, sector 23, fund size 22, website 23. In the paid file: named decision-makers on 22 rows, firm email on 8, LinkedIn page on 15, check size on 1.

## Questions
### How many biotech investors in Texas are there?
We list 23 as of November 2026. 17 of the 23 have a fund filing or a dated deal in the last 12 months. The cities with the most are Austin (14), Houston (5) and Dallas (2).

### Which biotech investors in Texas raised a new fund in the last 12 months?
14 of the 23 have a fund filing dated in the last 12 months. The most recent on this list are Hyve Ventures (Nov 2026), Audere (Oct 2026) and Transpose Platform (Sep 2026).

### What is the typical fund size of biotech investors in Texas?
The median fund size on file for this list is $50M, across the 19 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 4 do not disclose a size there.

### How do I contact biotech investors in Texas?
The paid file holds 123 named decision-makers across 22 of these 23 and a firm email for 8. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on biotech investors in Texas come from?
All 23 rows have an SEC filing on file (Form D or Form ADV). Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.